Abstract:To assess the effectiveness and molecular mechanisms of mild hypothermia and remote ischemic postconditioning (RIPC) in patients with acute ischemic stroke (AIS) who have undergone thrombolysis therapy. A total of 58 AIS patients who received recombinant tissue plasmin activator (rt-PA) intravenous thrombolysis were included in this prospective study. Participants were randomly allocated to the experimental group (rt-PA intravenous thrombolysis plus mild hypothermic ice cap plus remote ischemic brain protection, n = 30) and the control group (rt-PA intravenous thrombolysis plus 0.9% saline, n = 28). The RIPC was performed for 14 consecutive days on both upper limb arteries spaced 2 minutes apart. Five cycles of ischemia-reperfusion were performed sequentially (2-2, 3-3, 4-4, 5-5, 5-0 minutes, respectively). The outcome measures of the National Institute of Health stroke scale (NIHSS) score, volume of cerebral infarction, serum levels of superoxide dismutase (SOD), malondialdehyde (MDA), interleukin-1β, tumor necrosis factor α, nuclear factors kappa B (NF-κB), and NOD-1ike receptor pyrin 3 (NLRP3) were evaluated at different time points after treatment. Similarly, the 90-day modified Rankin Scale (mRS) scores were compared between the two groups. After treatment, the NIHSS score, MDA, NF-κB, and NLRP3 levels in the experimental group were significantly lower than those in the control group (p < 0.05). While the SOD in the experimental group was significantly higher than in the control group (p < 0.05), the NIHSS scores decreased within groups (all p < 0.05) in both experimental and control groups. The 90-day mRS score (0-2 points) in the experimental group was significantly higher than that in the control group (73.33% vs. 53.57%, p < 0.05) and no significant differences were observed in the safety indices between the two groups (all p > 0.05). Our study shows that combining mild hypothermia and RIPC has a positive effect on brain protection and can significantly reduce the oxidative stress and associated outburst of inflammatory response. The Clinical Trial Registration number is ChiCTR2300073136.

Hypoxic postconditioning drives protective microglial responses and ameliorates white matter injury after ischemic stroke

Brain‐selective Mild Hypothermia Promotes Long‐term White Matter Integrity after Ischemic Stroke in Mice

Mild Focal Hypothermia Regulates the Dynamic Polarization of Microglia after Ischemic Stroke in Mice

Hypoxic postconditioning modulates neuroprotective glial reactivity in a 3D cortical ischemic-hypoxic injury model

Hypoxic postconditioning promotes neurogenesis by modulating the metabolism of neural stem cells after cerebral ischemia

Hypoxic preconditioning improves long‐term functional outcomes after neonatal hypoxia–ischemic injury by restoring white matter integrity and brain development

Remote Limb Ischemic Postconditioning Protects Against Ischemic Stroke Via Modulating Microglia/Macrophage Polarization In Mice

The Roles of P38 MAPK/MSK1 Signaling Pathway in the Neuroprotection of Hypoxic Postconditioning Against Transient Global Cerebral Ischemia in Adult Rats

Mild Therapeutic Hypothermia Protects the Brain from Ischemia/Reperfusion Injury through Upregulation of iASPP.

Ischemic Postconditioning Protects Against Focal Cerebral Ischemia by Inhibiting Brain Inflammation While Attenuating Peripheral Lymphopenia in Mice

Remote Limb Ischemic Postconditioning Ameliorated Microglia-Mediated Inflammation Against Cerebral Ischemia/Reperfusion through Modulating Microglial Activation and Polarization via TLR4 Pathway

Perioperative stroke deteriorates white matter integrity by enhancing cytotoxic CD8+ T-cell activation

Optogenetic Stimulation of Mpfc Alleviates White Matter Injury‐Related Cognitive Decline after Chronic Ischemia Through Adaptive Myelination

Microglial depletion abolishes ischemic preconditioning in white matter

Microglial Hv1 Proton Channels Promote White Matter Injuries after Chronic Hypoperfusion in Mice.

Hypoxic Preconditioning Attenuates Neuroinflammation via Inhibiting NF-κB/NLRP3 Axis Mediated by p-MLKL after Transient Global Cerebral Ischemia

Brain Protection Effects of Mild Hypothermia Combined with Distant Ischemic Postconditioning and Thrombolysis in Patients with Acute Ischemic Stroke

MSK-1 and CREB are involved in HPC-induced neuroprotection against cerebral ischemic injuries of mice

CD11c+ Microglia Promote White Matter Repair after Ischemic Stroke.

Pharmacological hypothermia induced neurovascular protection after severe stroke of transient middle cerebral artery occlusion in mice

A Post-stroke Therapeutic Regimen with Omega-3 Polyunsaturated Fatty Acids that Promotes White Matter Integrity and Beneficial Microglial Responses after Cerebral Ischemia